Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)

• Status: Completed
• Trial end date: 2011-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This post-marketing surveillance study is to investigate the efficacy and safety of azathioprine tablets in subjects whom lung transplantation is performed.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Azathioprine

Criteria

Inclusion Criteria:

• Subjects who undergo lung transplantation and azathioprine tablets were administered

Exclusion Criteria:

• Subjects with hypersensitivity to the ingredients of azathioprine tablet

• Subjects who is pregnant or might be pregnant

• Subjects whose white count is lower than 3000/cubic millimeter